These clinical data suggest SRSF9 as a proto-oncogene in CRC, similar to its role in glioblastoma, squamous cell lung carcinoma, malignant melanoma [16] and bladder cancer [34]. Here, SRSF9 is linked to squamous cell lung carcinoma.